Biomarkers and new target drugs in autism spectrum disorders

被引：0
|
作者：
Persico, A. M. [1 ,2 ]
Buitelaar, J. K. [3 ]
机构：
[1] Univ Campus Biomed, Child & Adolescent Neuropsychiat Unit, Rome, Italy
[2] Lab Mol Psychiat & Neurogenet, Rome, Italy
[3] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70125-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S.01.04
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [1] Biomarkers for autism spectrum disorders
    Ecker, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S140 - S140
  • [2] Identification and validation of biomarkers for autism spectrum disorders
    Loth, Eva
    Spooren, Will
    Ham, Lindsay M.
    Isaac, Maria B.
    Auriche-Benichou, Caroline
    Banaschewski, Tobias
    Baron-Cohen, Simon
    Broich, Karl
    Boelte, Sven
    Bourgeron, Thomas
    Charman, Tony
    Collier, David
    de Andres-Trelles, Fernando
    Durston, Sarah
    Ecker, Christine
    Elferink, Andre
    Haberkamp, Marion
    Hemmings, Robert
    Johnson, Mark H.
    Jones, Emily J. H.
    Khwaja, Omar S.
    Lenton, Sabine
    Mason, Luke
    Mantua, Valentina
    Meyer-Lindenberg, Andreas
    Lombardo, Michael V.
    O'Dwyer, Laurence
    Okamoto, Koichi
    Pandina, Gahan J.
    Pani, Luca
    Persico, Antonio M.
    Simonoff, Emily
    Tauscher-Wisniewski, Sitra
    Llinares-Garcia, Jordi
    Vamvakas, Spiros
    Williams, Steve
    Buitelaar, Jan K.
    Murphy, Declan G. M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (01) : 70 - 73
  • [3] Identification and validation of biomarkers for autism spectrum disorders
    Eva Loth
    Will Spooren
    Lindsay M. Ham
    Maria B. Isaac
    Caroline Auriche-Benichou
    Tobias Banaschewski
    Simon Baron-Cohen
    Karl Broich
    Sven Bölte
    Thomas Bourgeron
    Tony Charman
    David Collier
    Fernando de Andres-Trelles
    Sarah Durston
    Christine Ecker
    Andre Elferink
    Marion Haberkamp
    Robert Hemmings
    Mark H. Johnson
    Emily J. H. Jones
    Omar S. Khwaja
    Sabine Lenton
    Luke Mason
    Valentina Mantua
    Andreas Meyer-Lindenberg
    Michael V. Lombardo
    Laurence O'Dwyer
    Koichi Okamoto
    Gahan J. Pandina
    Luca Pani
    Antonio M. Persico
    Emily Simonoff
    Sitra Tauscher-Wisniewski
    Jordi Llinares-Garcia
    Spiros Vamvakas
    Steve Williams
    Jan K. Buitelaar
    Declan G. M. Murphy
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 70 - 70
  • [4] Biomarkers in autism spectrum disorders: Current progress
    Shen, Liming
    Liu, XuKun
    Zhang, Huajie
    Lin, Jing
    Feng, Chengyun
    Iqbal, Javed
    [J]. CLINICA CHIMICA ACTA, 2020, 502 : 41 - 54
  • [5] Potential cytokine biomarkers in autism spectrum disorders
    Rose, Destanie
    Ashwood, Paul
    [J]. BIOMARKERS IN MEDICINE, 2014, 8 (09) : 1171 - 1181
  • [6] Potential Biomarkers for Diagnosis and Screening of Autism Spectrum Disorders
    Meiliana, Anna
    Wijaya, Andi
    [J]. INDONESIAN BIOMEDICAL JOURNAL, 2014, 6 (03): : 137 - 156
  • [7] Antiepileptic drugs: Affective use in autism spectrum disorders
    Di Martino, A
    Tuchman, RF
    [J]. PEDIATRIC NEUROLOGY, 2001, 25 (03) : 199 - 207
  • [8] New insight into autism spectrum disorders
    Laffman-Johnson, Elise
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (03) : 231 - 231
  • [9] DRUGS TO TREAT VARIOUS NEURODEVELOPMENTAL AND AUTISM SPECTRUM DISORDERS
    不详
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2022, 60 (11)
  • [10] New perspectives in autism spectrum disorders
    Thibaut, Florence
    [J]. DIALOGUES IN CLINICAL NEUROSCIENCE, 2017, 19 (04) : 323 - 323
12345